CRENESSITY
Live / Applied — Second extension granted (statement of use) (as of 23 Dec 2025)
What this means for you
Not registered yet, but its 14 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98404854
- Mark type
- Stylized text
- Filed
- 14 Feb 2024
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 042 — Scientific and technological services: Providing medical research information; providing medical research information in the field of pharmaceuticals and clinical trials focusing on other endocrine diseases and disorders; Scientific research in the nature of conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders, for others; conducting post-authorization pharmaceutical research for the marketing of pharmaceutical preparations and evaluating epidemiological results
- Class 044 — Medical, beauty and agricultural services: Providing medical information; Providing medical information to insurance companies in the field of congenital adrenal hyperplasia; Providing medical information to patients, medical professionals, and insurance companies in the field of other endocrine diseases and disorders; on-line information services, namely, providing medical information to insurance companies in the field of congenital adrenal hyperplasia; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of other endocrine diseases and disorders
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 23 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Dec 2025 — SOU EXTENSION 2 GRANTED
- 18 Dec 2025 — SOU EXTENSION 2 FILED
- 19 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Aug 2025 — CORRECTED NOA E-MAILED
- 22 Aug 2025 — DIVISIONAL PROCESSING COMPLETE
- 07 Apr 2025 — DIVISIONAL REQUEST RECEIVED
- 23 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Apr 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2025 — SOU EXTENSION 1 GRANTED
- 25 Feb 2025 — SOU EXTENSION 1 FILED